Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details 1)

v3.8.0.1
Stock Based Compensation (Details 1) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2017
Dec. 31, 2016
Number of Options    
Number of Options, Exercised (25,995)  
Stock Options [Member] | Consultants [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Options Available for Grant, Outstanding, Beginning Balance 90,303 99,303
Options Available for Grant, Granted   (9,000)
Options Available for Grant, Exercised
Options Available for Grant, Outstanding, Ending Balance 99,303 90,303
Number of Options    
Number of Options, Outstanding, Beginning balance 177,461 306,773
Number of Options, Granted 9,000
Number of Options, Exercised (5,000) (138,312)
Number of Options, Outstanding, Ending balance 172,461 177,461
Weighted Average Exercise Price per Option    
Weighted Average Exercise Price per Option, Outstanding, Beginning Balance $ 0.49 $ 0.36
Weighted Average Exercise Price per Option, Granted   4.99
Weighted Average Exercise Price per Option, Exercised 1.50 0.34
Weighted Average Exercise Price per Option, Outstanding, Ending Balance 0.57 0.49
Weighted Average Grant Date Fair Value per Option, Outstanding, Beginning Balance 1.05 1.01
Weighted Average Grant Date Fair Value per Option, Granted   0.44
Weighted Average Grant Date Fair Value per Option, Exercised 0.83 0.81
Weighted Average Grant Date Fair Value per Option, Outstanding, Ending Balance $ 1.11 $ 1.05
Weighted Average Remaining Exercise Term in Months    
Weighted Average Remaining Exercise Term in Months, Outstanding, Beginning Balance 37 months 41 months
Weighted Average Remaining Exercise Term in Months, Granted   52 months
Weighted Average Remaining Exercise Term in Months, Outstanding, Ending Balance 32 months 37 months